First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis

por Renders, Lutz, Budde, Klemens, Rosenberger, Christian, van Swelm, Rachel, Swinkels, Dorine, Dellanna, Frank, Feuerer, Werner, Wen, Ming, Erley, Christiane, Bader, Birgit, Sommerer, Claudia, Schaier, Matthias, Meurer, Karoline, Matis, Louis
Publicado 2019

Interim analysis of the COSA (COVID-19 patients treated with the Seraph(®) 100 Microbind(®) Affinity filter) registry

por Schmidt, Julius J, Borchina, Dan Nicolae, van't Klooster, Mariet, Bulhan-Soki, Khalida, Okioma, Reuben, Herbst, Larissa, Rodríguez, Diego Sandoval, Premužić, Vedran, Büttner, Stefan, Bader, Birgit, Serednicki, Wojciech, Zasada, Ewa, Schmitz, Michael, Quabach, Ralf A, Hrincheva, Maria, Fühner, Thomas, Kielstein, Jan T
Publicado 2021